Fun with Finances
VC Investments in Biotech Continue Strong Trend
By Brian Orelli
Tuesday, October 1, 2013
After an insane second quarter, funding of U.S. biotechs by venture capital cooled off a bit as the weather warmed up. But cooled off is all relative.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.